Erchonia Medical was the first company to obtain FDA Market clearance for a low –level laser. The clearance, received on January 17, 2002, was the culmination of 2 years of efforts and two IRB approved studies. Needless to say, we blazed the trail for low level laser and established a standing prescient for ourselves, that being – all Erchonia Medical indications for use, would be verifiable through clinical research.

At present we have the following 510(K) market clearances:

TUCO Erchonia PL3000

Erchonia EML Laser

Erchonia EVRL Laser

Breast Augmentation